Vanguard Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Other funds holding IOVA
Vanguard Capital Management's IOVA Position: Q3 2026 in Review
Vanguard Capital Management increased its Iovance Biotherapeutics (IOVA) stake by 1.1% in Q3 2026, buying an estimated $1.38M and bringing the position to 18,396,706 shares worth $273M. The position accounts for 0.01% of the portfolio, ranked #916.
Vanguard Capital Management first reported a position in IOVA in Q1 2026 and has held it in 3 quarters since. 334 funds tracked by Wall St. Rank hold IOVA as of Q3 2026.
- Vanguard Capital Management held 18,396,706 shares of Iovance Biotherapeutics worth $273M as of Q3 2026.
- Vanguard Capital Management bought 192,458 Iovance Biotherapeutics shares in Q3 2026, an estimated $1.38M.
- Iovance Biotherapeutics made up 0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #916 holding.
- Vanguard Capital Management first reported a position in Iovance Biotherapeutics in Q1 2026 and has held it in 3 quarters since.
- 334 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.